<DOC>
	<DOCNO>NCT00421590</DOCNO>
	<brief_summary>This study assess effect concomitant antacid pharmacokinetics pharmacodynamics SMC021</brief_summary>
	<brief_title>Drug Interaction SMC021 With Concomitant Antacid ( Calcium Carbonate/Magnesium Hydroxide ) .</brief_title>
	<detailed_description />
	<mesh_term>Calcium Carbonate</mesh_term>
	<mesh_term>Antacids</mesh_term>
	<mesh_term>Magnesium Hydroxide</mesh_term>
	<mesh_term>Anti-Ulcer Agents</mesh_term>
	<criteria>Healthy postmenopausal female subject , 40 70 year age , good health determine past medical history , physical examination , vital sign , electrocardiogram , laboratory test screen . At Screening , Baseline , vital sign ( systolic diastolic blood pressure pulse rate ) assess subject rest least three ( 3 ) minute . All blood pressure measurement timepoints assess subject seat , utilize arm determination . Postmenopausal woman must regular menstrual bleeding least 5 year prior inclusion must surgically sterilize least 6 month prior screen . Body mass index ( BMI ) must within range 18 30 . Subjects must weigh least 50 kg participate study . Able communicate well investigator , understand comply requirement study . Understand sign write informed consent . Smokers report cigarette use â‰¥ 5 cigarette per day . Smoking allowed day dose last blood sample last assessment . Use prescription drug overthecounter ( OTC ) medication ( vitamin , herbal supplement , dietary supplement ) start within last month prior screen . Participation clinical investigation within 4 week prior dose , less 10 time correspond half life drug take . The current previous treatment would affect bone metabolism/remodeling . Donation loss 400 mL blood within 8 week prior first dose , longer required local regulation . Subjects hemoglobin level equal 7.5 mmol/L screening . Significant illness within two week prior dose . A past medical history clinically significant ECG abnormality family history grandparent , parent sibling ) prolong QTinterval syndrome . History autonomic dysfunction ( e.g . history fainting , orthostatic hypotension , sinus arrhythmia ) . History acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat treat ) , History clinically significant drug allergy history atopic allergy ( asthma , urticaria , eczematous dermatitis ) . A known hypersensitivity study drug drug similar study drug . Any surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug may jeopardize subject case participation study . Poorly control diabetes History malignancy organ system within past 5 year A positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C test result . HIV positive History drug alcohol abuse within 12 month prior dose . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Randomized , partially blind , placebo control , crossover , drug interaction concomitant antacid , pharmacokinetics , pharmacodynamics , SMC021</keyword>
</DOC>